Addex Therapeutics Ltd (FRA:APE)

Germany flag Germany · Delayed Price · Currency is EUR
0.0560
0.00 (0.00%)
At close: Dec 3, 2025
40.00%
Market Cap 6.64M
Revenue (ttm) 169.46K
Net Income (ttm) -6.52M
Shares Out n/a
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0560
Previous Close 0.0560
Day's Range 0.0560 - 0.0560
52-Week Range 0.0030 - 0.0810
Beta n/a
RSI 59.88
Earnings Date Nov 10, 2025

About Addex Therapeutics

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson’s disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mG... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol APE
Full Company Profile

Financial Performance

Financial numbers in CHF Financial Statements

News

There is no news available yet.